Published in Pain on April 01, 1995
Mu opioids and their receptors: evolution of a concept. Pharmacol Rev (2013) 1.66
Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway. Am J Pathol (2010) 1.11
Morphine inhibits murine dendritic cell IL-23 production by modulating Toll-like receptor 2 and Nod2 signaling. J Biol Chem (2011) 1.00
Chronic morphine administration delays wound healing by inhibiting immune cell recruitment to the wound site. Am J Pathol (2009) 0.99
Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection. Infect Immun (2009) 0.99
Symbiotic relationship of pharmacogenetics and drugs of abuse. AAPS J (2006) 0.93
Integration of palliative care in chronic critical illness management. Respir Care (2012) 0.79
Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study. BMC Palliat Care (2015) 0.79
[Opioids for noncancer pain in the elderly]. Schmerz (2015) 0.78
Integrating palliative care with intensive care for critically ill patients with lung cancer. Ann Intensive Care (2012) 0.77
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals. Clin Pharmacokinet (2016) 0.75
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer (1994) 5.63
Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol (1996) 4.07
Defining the clinically important difference in pain outcome measures. Pain (2000) 3.88
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res (2000) 3.83
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist (2000) 3.62
Pain measurement: an overview. Pain (1985) 3.54
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27
Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol (2000) 3.26
Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg (1995) 3.24
Distribution of brain metastases. Arch Neurol (1988) 3.11
Clinical classification of cardiac deaths. Circulation (1982) 2.93
The treatment of cancer pain. N Engl J Med (1985) 2.71
Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst (1995) 2.70
Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage (1990) 2.48
Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res (1994) 2.46
Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain (1986) 2.44
The management of cancer pain. CA Cancer J Clin (1994) 2.41
The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain (1990) 2.37
Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol (1996) 2.30
Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med (1993) 2.22
Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology (1990) 2.13
An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain (1999) 2.09
Determinants of the willingness to endorse assisted suicide. A survey of physicians, nurses, and social workers. Psychosomatics (1997) 2.06
The memorial symptom assessment scale short form (MSAS-SF). Cancer (2000) 1.94
Competent care for the dying instead of physician-assisted suicide. N Engl J Med (1997) 1.94
The measurement of symptoms in children with cancer. J Pain Symptom Manage (2000) 1.85
Chronic vascular catheterization in the rat: comparison of three techniques. Physiol Behav (1984) 1.76
Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. Ann Intern Med (1977) 1.74
Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol (1983) 1.74
A peaceful death: how to manage pain and provide quality care. A roundtable discussion: Part 2. Geriatrics (1996) 1.72
Merkel cell carcinoma. Prognosis and management. Arch Surg (1991) 1.72
Brachial plexus lesions in patients with cancer: 100 cases. Neurology (1981) 1.70
Pain and its persistence in herpes zoster. Pain (1996) 1.68
Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage (1999) 1.68
Pain relief into practice: rhetoric without reform. J Clin Oncol (1995) 1.64
Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther (1989) 1.64
Pain syndromes in multiple sclerosis. Neurology (1988) 1.63
Adult brainstem gliomas. Neurology (1998) 1.61
Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease. Neurology (1988) 1.59
Steroid myopathy in cancer patients. Neurology (1997) 1.57
The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain. Cancer (1987) 1.57
Anomalous bilateral single pulmonary vein demonstrated by 3-dimensional reconstruction of helical computed tomographic angiography: case report. Can Assoc Radiol J (1998) 1.56
Morphine-6-glucuronide, a potent mu agonist. Life Sci (1987) 1.55
Combined modality therapy for primary CNS lymphoma. J Clin Oncol (1992) 1.53
Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol (1998) 1.53
Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Symptom Manage (1990) 1.52
Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol (2001) 1.48
Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol (1995) 1.47
Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates. Pain (1996) 1.46
Neuropsychological characterization of the AIDS dementia complex: a preliminary report. AIDS (1988) 1.46
The pharmacokinetics of heroin in patients with chronic pain. N Engl J Med (1984) 1.46
Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain (2001) 1.43
An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice. Brain Res Bull (1996) 1.42
Central pain from cerebral abscess: thalamic syndrome in AIDS patients with toxoplasmosis. Neurology (1992) 1.42
Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer (2000) 1.41
The undertreatment of pain in ambulatory AIDS patients. Pain (1997) 1.40
The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery (1989) 1.40
Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care (1994) 1.38
Individual variability in the response to different opioids: report of five cases. Pain (1992) 1.36
Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature (1993) 1.36
Pain syndromes and etiologies in ambulatory AIDS patients. Pain (1997) 1.35
Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci (1983) 1.30
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27
The levels of methadone in the plasma in methadone maintenance. Clin Pharmacol Ther (1972) 1.27
The importance of clinical staging of minor salivary gland carcinoma. Am J Surg (1991) 1.26
Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol (1994) 1.26
Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma. Am J Surg Pathol (1977) 1.25
Prognosis of node-positive colon cancer. Cancer (1991) 1.23
A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. J Pain Symptom Manage (2000) 1.22
Pain management in patients with pancreatic carcinoma. Cancer (1996) 1.20
Quality of life of women with ovarian cancer. Gynecol Oncol (1995) 1.19
Prostaglandins in breast cancer: relationship to disease stage and hormone status. Br J Cancer (1983) 1.19
The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer (1992) 1.18
How accurate is fetal biometry in the assessment of fetal age? Am J Obstet Gynecol (1998) 1.18
The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function. Clin Pharmacol Ther (1992) 1.18
Methadone assays in pregnant women and progeny. Am J Obstet Gynecol (1975) 1.18
The non-Hodgkin's lymphomas. I. A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958 and 1969. Cancer (1983) 1.18
d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. J Pharmacol Exp Ther (1999) 1.18
Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage (1990) 1.17
The single supratentorial lesion. An evaluation of preoperative diagnostic tests. J Neurosurg (1980) 1.16
End-of-life care: a survey of US neurologists' attitudes, behavior, and knowledge. Neurology (1999) 1.16
Responding to intractable terminal suffering. Ann Intern Med (2000) 1.16
Pain in ambulatory AIDS patients. II: Impact of pain on psychological functioning and quality of life. Pain (1996) 1.16
Sublingual absorption of selected opioid analgesics. Clin Pharmacol Ther (1988) 1.15